Investigating the cellular targets of HIV protease inhibitors: implications for metabolic disorders and improvements in drug therapy.
about
Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.HIV protease inhibitors acutely impair glucose-stimulated insulin release.Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.
P2860
Investigating the cellular targets of HIV protease inhibitors: implications for metabolic disorders and improvements in drug therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Investigating the cellular tar ...... improvements in drug therapy.
@ast
Investigating the cellular tar ...... improvements in drug therapy.
@en
type
label
Investigating the cellular tar ...... improvements in drug therapy.
@ast
Investigating the cellular tar ...... improvements in drug therapy.
@en
prefLabel
Investigating the cellular tar ...... improvements in drug therapy.
@ast
Investigating the cellular tar ...... improvements in drug therapy.
@en
P356
P1476
Investigating the cellular tar ...... d improvements in drug therapy
@en
P2093
P356
10.2174/1568005024605882
P50
P577
2002-03-01T00:00:00Z